Your session is about to expire
← Back to Search
Behavioral Intervention
BE-SMART for Mood Disorders (BE-SMART Trial)
N/A
Waitlist Available
Led By Hilary P Blumberg, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 12 weeks
Awards & highlights
BE-SMART Trial Summary
This trial is testing a new psychotherapy treatment to help reduce emotional dysregulation in people with mood disorders. Investigators will assess whether the treatment can improve functioning of emotion regulation brain circuitry.
BE-SMART Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
FMRI BOLD Signal Changes in Left Amygdala at Baseline and Midpoint
Functional Magnetic Resonance Imaging (fMRI) Blood Oxygen-level Dependent (BOLD) Signal Changes in Left Amygdala at Baseline and at the End of the Intervention
fMRI Functional Connectivity Changes in VPFC From an Amygdala Seed Region at Baseline and Endpoint
+1 moreBE-SMART Trial Design
1Treatment groups
Experimental Treatment
Group I: BE-SMARTExperimental Treatment1 Intervention
Psychobehavioral intervention with focus either on teaching emotional regulation skills or regularizing daily sleep and activity levels.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BE-SMART
2017
N/A
~80
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,848 Previous Clinical Trials
2,737,742 Total Patients Enrolled
6 Trials studying Mood Disorders
591 Patients Enrolled for Mood Disorders
National Institute of Mental Health (NIMH)NIH
2,783 Previous Clinical Trials
2,689,051 Total Patients Enrolled
74 Trials studying Mood Disorders
45,509 Patients Enrolled for Mood Disorders
Hilary P Blumberg, MDPrincipal InvestigatorYale School of Medicine
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger